Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy

NCT03193437 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Slow Accrual

Conditions

Thymoma
Advanced Thymic Epithelial Tumor

Interventions

DRUG: Open Label Selinexor

Sponsor

Georgetown University

Collaborators

[object Object]
[object Object]